The government is now operating in accordance with the Guidance on Caretaker Conventions, pending the outcome of the 2025 federal election.
You are here Home Guidance and resources Sponsors BeiGene AUS Pty Ltd Regulatory activities for this sponsor. Listen Print Share Loading... Type Prescription medicine evaluation (2) (-) Prescription medicine evaluation (2) Prescription medicine registration (6) Prescription medicine registration (6) Australian Public Assessment Report (AusPAR) (4) Australian Public Assessment Report (AusPAR) (4) Designation or determination (3) Designation or determination (3) Prescription medicine decision summary (3) Prescription medicine decision summary (3) ARTG (2) ARTG (2) Cancellation by sponsor (1) Cancellation by sponsor (1) Show more Date 2024 (2) 2024 (2) Search Filters applied:Prescription medicine evaluationClear all Sponsor content2 result(s) found, displaying 1 to 2 TEVIMBRA Beigene Aus Pty Ltd Jul-2024 Prescription medicine evaluation Active ingredient: tislelizumab. TEVIMBRA Beigene Aus Pty Ltd Apr-2024 Prescription medicine evaluation Active ingredient: tislelizumab.
TEVIMBRA Beigene Aus Pty Ltd Jul-2024 Prescription medicine evaluation Active ingredient: tislelizumab.
TEVIMBRA Beigene Aus Pty Ltd Apr-2024 Prescription medicine evaluation Active ingredient: tislelizumab.